medigraphic.com
Anales de Otorrinolaringología Mexicana

2007, Number 3

<< Back Next >>

Otorrinolaringología 2007; 52 (3)

Mitochondrial hereditary diseases with deafness (part two)

Domínguez-Aburto LJE, Huesca HF

Language: Spanish
References: 60
Page: 102-110
PDF size: 175.31 Kb.


ABSTRACT

Mitochondrial hereditary diseases world and knowledge are more and more complete. Findings will continue transforming and evolving medicine and genetics till unsuspected frontiers. This review analyzes mitochondrial factors associated with deafness, since pure hereditary mitochondrial till ototoxicity. We hope this synopsis help to understand this complex process.


REFERENCES

  1. De Coo IFM, Smeets HJM, Gabreels FJM, Arts N, van Oost BA. Isolated case of mental retardation and ataxia due to a de novo mitochondrial T8993G mutation. Am J Hum Genet 1996;58:636-8.

  2. Barrera-Ramírez CF, Barragán-Campos HM, Sánchez Guerrero J, García-Ramos G, y col. El otro genoma: el concepto clínico de las citopatías mitocondriales o enfermedades de la fosforilación oxidativa. Rev Invest Clin 1999;51:121-34.

  3. López de Monain A. Clasificación de las enfermedades mitocondriales. Rev Neural 1998;26(Supl 1):S9-S14.

  4. Solano A, Payán A, López-Pérez MJ, Montoya J. Enfermedades Genéticas del ADN Mitocondrial Humano. Salud Pública Mex 2001;43:151-61.

  5. Koo B. Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes (MELAS): clinical radiological, pathological, and genetic observations. Ann Neural 1993;34(1):25-32.

  6. Willems PL. Genetic causes of hearing loss. New Eng J Med 2000;342(15):1101-9.

  7. De Toledo M, Díaz-Guzmán J, Pérez-Martínez DA, Saiz-Díaz RA, y col. Síndrome MELAS que se asemeja a una encefalitis por virus herpes: diagnóstico genético. Rev Neural 2001;33(2):148-50.

  8. Goto Y, Tsugane K, Tanabe Y, Nanaka I, Horai S. A new point mutation at nucleotide par 3291 of the mitochondrial tRNA (Leu [UUR]) gene in a patient with mitochondrial myopaty, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem Biophys Res Commun 1994;202:1624-30.

  9. Goto Y, Nonaka I, Horai S. A mutation in the RNAt (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348(6302):651-3.

  10. Ballinger SW, Shoffner JM, Hedaya EV, Trounce I, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet 1992:1(1):11-15.

  11. Ballinger SW, Shoffner JM, Gebhart S, Koontz DA, Wallace DC. Mitochondrial diabetes revisited. Nat Genet 1994;7:458-9.

  12. Maassen JA, Jansen JJ, Kadowaki T, Van den Ouweland JM, et al. The molecular basis and clinical characteristics of maternally inherited diabetes and deafness (MIDD) a recently recognized diabetic subtype. Exp Clin Endocrinol Diabetes 1996;104:205-11.

  13. Velho G, Byrne MM, Clement K, Sturis J, et al. Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNA Leu (UUR) gene mutation. Diabetes 1996;45:478-87.

  14. Van Camp G, Smith RJ. Maternally inherited hearing impairment. Clin Genet 2000;57(6):409-14.

  15. van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, et al. Mutation in mitochondrial tRNA (leu) (UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992;1:368-71.

  16. Kadowaki T, Kadowaki H, Mori Y, Tobe K, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994;330(14):962-8.

  17. Newkirk JE, Taylor RW, Howell N, Bindoff LA, et al. Maternally inherited diabetes and deafness: prevalence in a hospital diabetic population. Diabet Med 1997;14(6):457-60.

  18. Ciafaloni E, Ricci E, Shanske S, Moraes CT, et al. MELAS: clinical features, biochemistry and molecular genetics. Ann Neural 1992;31:391-8.

  19. Rusanen H, Majamaa K, Tolonen U, Remes AM, et al. Demyelinating polyneuropathy in a patient with the tRNA Leu (UUR) mutation at base pair 3243 of the mitochondrial DNA. Demyelinating polyneuropathy in a patient with the tRNA Leu (UUR) mutation at base pair 3243 of the mitochondrial DNA. Neurology 1995;45:1188-92.

  20. ‘t Hart LM, Jansen JJ, Lemkes HHPJ, de Knijff P, Maassen JA. Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leukocyte DNA upon aging. Hum Mutat 1996;7:193-7.

  21. Montoya J, Payán A, Alcaine ML, Solano A, y col. Genética de las epilepsias mitocondriales. Rev Neurol 2000;30:330-2.

  22. Anan R, Nakagawa M, Miyata M, Higuchi I, et al. Cardiac involvement in mitochondrial disease. Study on 17 patients documented mitochondrial DNA defects. Circulation 1995;95:955-61.

  23. Mancuso M, Filosto M, Mootha VK, Rocchi A, et al. A novel mitochondrial tRNA-phe mutation causes MERRF syndrome. Neurology 2004;62:2119-21.

  24. Cabello A, Navarro C, Ricoy JR. Alteraciones morfológicas de las miopatías mitocondriales. Rev Neural 1998;26(Supl 1):S44-S49.

  25. Silvestri G, Morales CT, Shanske S, Oh SI, DiMauro S. A new mutation in the trans-RNA (lys) gene associated with myoclonic epilepsy and ragged-red fibres (MERRF). Am J Hum Genet 1992;51:1213-7.

  26. Chomyn A. The myoclonic epilepsy and ragged-red fiber mutation provides new insights into human mitochondrial function and genetics. Am J Hum Genet 1998;62:745-51.

  27. Yoneda M, Miyatake T, Attardi G. Heteroplastic mitochondrial tRNAlys mutation and its complementation in MERRF patient-derived mitochondrial transformants. Muscle Nerve 1995;3:S95-S101.

  28. Kearns TP. External ophthalmoplegia, pigmentary degeneration of the retina, and cardiomyopathy: a newly recognized syndrome. Trans Ophthal Soc 965;63:559-625.

  29. Shoubridge EA, Johns T, Karpati G. Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy. Hum Molec Genet 1997;6:2239-42.

  30. Varón-Munar DT, Ramírez-Ortiz MA, Cano-Hidalgo RA, Salazar-León JA. Enfermedades congénitas y anomalías del desarrollo. Síndrome de Kearns-Sayre. Reporte de un caso. Rev Mex Oftalmol 1994;68(2):81-84.

  31. Lestienne P, Ponsot G. Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1988;1:885.

  32. Riordan-Eva P, Harding AE. Leber’s hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations. J Med Genet 1995:32:81-87.

  33. Larsson NG, Andersen O, Holme E, Oldfors A, Wahlstrom J. Leber’s hereditary optic neuropathy and complex I deficiency in muscle. Ann Neural 1991;30:701-8.

  34. Majander A, Huoponen K, Savontaus ML, Nikoskelainen E, Wikstrom M. Electron transfer properties of NADH: ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON). FEBS Lett 1991;292:289-92.

  35. Howell N, Bindoff LA, McCullough DA, Kubacka I, et al. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991;49:939-50.

  36. Parker WD, Oley CA, Parks JA. A defect in mitochondrial electron-transport activity (NADH-Coenzyme Q oxidoreductase) in Leber’s hereditary optic neuropathy. New Eng J Med 1989;320:1331-3.

  37. Rotig A, Bessis JL, Romero N, Cormier V, et al. Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia. Am J Hum Genet 1992;50:364-70.

  38. Rotig A, Cormier V, Chatelain P, Francois R, et al. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). J Clin Invest 1993;91:1095-8.

  39. Bundey S, Poulton K, Whitwell H, Curtis E, et al. Mito- chondrial abnormalities in the DIDMOAD syndrome. J Inherit Metab Dis 1992;15:315-9.

  40. Pilz D, Quarrell OWJ, Jones EW. Mitochondrial mutation commonly associated with Leber’s hereditary optic neuropathy observed in a patient with Wolfram syndrome (DIDMOAD). J Med Genet 1994;31:328-30.

  41. Barrientos A, Volpini V, Casademont J, Genis D, et al. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J Clin Invest 1996;97:1570-6.

  42. Hofmann S, Bezold R, Jaksch M, Obermaier-Kusser B, et al. Wolfram (DIDMAOD) syndrome and Leber hereditary optic neuropathy (LHON) are associated with distinct mitochondrial DNA haplotypes. Genomics 1997;39:8-18.

  43. Reid FM, Vernham GA, Jacobs HT. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum Mutat 1994;3:243-7.

  44. Sevior KB, Hatamochi A, Stewart IA, Bykhovskaya Y, et al. Mitochondrial A7445G mutation in two pedigrees with palmoplantar keratoderma and deafness. Am J Med Genet 1998;75:179-85.

  45. Guan MX, Enriquez JA, Fischel-Ghodsian N, Puranam RS, et al. The deafness-associated mitochondrial DNA mutation at position 7445, which effects tRNA-ser (UCN) precursor processing, has long-range affects on NADH dehydrogenase subunit ND6 gene expression. Mol Cell Biol 1998;18:5868-79.

  46. Martin L, Toutain A, Guillen C, Haftek M, et al. Inherited palmoplantar keratoderma and sensorineural deafness associated with A7445G point mutation in the mitochondrial genome. Br J Derm 2000;143:876-83.

  47. Hutchin TP, Parker MJ, Young ID, Davis AC, et al. A novel mutation in the mitochondrial tRNA Ser (UCN) gene in a family with non-syndromic sensorineural hearing impairment. J Med Genet 2000;37:692-4.

  48. Jaber L, Shohat M, Bu X, Fischel-Ghodsian N, et al. Sensorineural deafness inherited as a tissue specific mitochondrial disorder. J Med Genet 1992;29: 86-90

  49. Prezant TR, Shohat M, Jaber L, Pressman S, Fischel- Ghodsian N. Biochemical characterization of a pedigree with mitochondrially inherited deafness. Am J Med Genet 1992;44:465-72.

  50. Prezant TR, Agapian JV, Bohlman MC, Bu X, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993;4:289-94.

  51. Bu X, Yang HY, Shohat M, Rotter JI. Two-locus mitochondrial and nuclear gene models for mitochondrial disorders. Genet Epidemiol 1992;9:27-44.

  52. Guan MX, Fischel-Ghodsian N, Attardi G. Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation. Hum Mol Genet 1996;5:963-71.

  53. Bykhovskaya Y, Shohat M, Ehrenman K, Johnson D, et al. Evidence for complex nuclear inheritance in a pedigree with nonsyndromic deafness due to a homoplasmic mitochondrial mutation. Am J Med Genet 1998;77:421-6.

  54. Bykhovskaya Y, Yang H, Taylor K, Hang T, et al. Modifier locus for mitochondrial DNA disease: linkage and linkage disequilibrium mapping of a nuclear modifier gene for maternally inherited deafness. Genet Med 2001;3:177-80.

  55. Nadeau JH. Modifier genes in mice and humans. Nature Rev Genet 2001;2:165-74.

  56. Bykhovskaya Y, Estivill X, Taylor K, Hang T, et al. Candidate locus for a nuclear modifier gene for maternally inherited deafness. Am J Hum Genet 2000;66:1905-10.

  57. Johnsonbaugh RE, Drexel HG, Light IJ, Sutherland JM. Familial occurrence of drug-induced hearing loss. Am J Dis Child 1974;127:245-7.

  58. Prazic M, Salaj B. Ototoxicity with children caused by streptomycin. Audiology 1975;14:173-6.

  59. Higashi K. Unique inheritance of streptomycin-induced deafness. Clin Genet 1989;35:433-6.

  60. Hu DN, Qiu WQ, Wu BT, Fang LZ, et al. Genetic aspects of antibiotic induced deafness: mitochondrial inheritance. J Med Genet 1991;28:79-83.




2020     |     www.medigraphic.com